688687 Stock Overview
Beijing Kawin Technology Share-Holding Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Beijing Kawin Technology Share-Holding Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥25.93 |
| 52 Week High | CN¥37.63 |
| 52 Week Low | CN¥18.50 |
| Beta | 1.09 |
| 11 Month Change | -4.95% |
| 3 Month Change | 29.71% |
| 1 Year Change | -13.22% |
| 33 Year Change | 2.33% |
| 5 Year Change | n/a |
| Change since IPO | -38.26% |
Recent News & Updates
Impressive Earnings May Not Tell The Whole Story For Beijing Kawin Technology Share-Holding (SHSE:688687)
Oct 28
Why Investors Shouldn't Be Surprised By Beijing Kawin Technology Share-Holding Co., Ltd.'s (SHSE:688687) 36% Share Price Surge
Oct 01Recent updates
Impressive Earnings May Not Tell The Whole Story For Beijing Kawin Technology Share-Holding (SHSE:688687)
Oct 28Why Investors Shouldn't Be Surprised By Beijing Kawin Technology Share-Holding Co., Ltd.'s (SHSE:688687) 36% Share Price Surge
Oct 01We Think Beijing Kawin Technology Share-Holding (SHSE:688687) Can Stay On Top Of Its Debt
May 06Beijing Kawin Technology Share-Holding Co., Ltd. (SHSE:688687) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable
Mar 14Shareholder Returns
| 688687 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -4.2% | -2.6% | -2.1% |
| 1Y | -13.2% | -20.9% | 2.8% |
Return vs Industry: 688687 exceeded the CN Biotechs industry which returned -17.3% over the past year.
Return vs Market: 688687 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
| 688687 volatility | |
|---|---|
| 688687 Average Weekly Movement | 9.3% |
| Biotechs Industry Average Movement | 8.9% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 688687 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688687's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 580 | Desheng Zhou | www.kawin.com.cn |
Beijing Kawin Technology Share-Holding Co., Ltd. engages in the development and production of pharmaceutical products primarily in the areas of liver diseases in China. The company’s products include recombinant human interferon alfa-2b injection; vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; and compound glycyrrhizin.
Beijing Kawin Technology Share-Holding Co., Ltd. Fundamentals Summary
| 688687 fundamental statistics | |
|---|---|
| Market cap | CN¥4.34b |
| Earnings (TTM) | CN¥134.34m |
| Revenue (TTM) | CN¥1.42b |
32.3x
P/E Ratio3.1x
P/S RatioIs 688687 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688687 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.42b |
| Cost of Revenue | CN¥248.63m |
| Gross Profit | CN¥1.17b |
| Other Expenses | CN¥1.04b |
| Earnings | CN¥134.34m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.80 |
| Gross Margin | 82.49% |
| Net Profit Margin | 9.46% |
| Debt/Equity Ratio | 14.4% |
How did 688687 perform over the long term?
See historical performance and comparison